Halliburton Shares Spike on Earnings and Settlement Deal

Michael Teague |

Halliburton Shares Spike on Earnings and Settlement DealShares for international oilfield services company Halliburton (HAL) were up over 5 percent on Monday, trading for as much as $39.41, after the company released its earnings report, and announced that it had been participating in an out of court settlement to deal with “a substantial portion” of private lawsuits relating to its role in the 2010 Gulf of Mexico oil disaster.

Excluding expenses, most notably the $637 million the company set aside during the first quarter for legal expenses resulting from the private claims that have been brought against it, Halliburton reported earnings of $624 million, or $0.67 cent per share, on record Q1 revenue of $6.97 billion. This was well in front of analyst estimates that predicted earnings of $0.57 cents per share on revenue of $6.88 billion.

Including expenses, however, the company reported a loss of $18 million, or $0.02 cents per share. Still, investors reacted favorably to news that the 11 percent decline in revenue from North American operations was cushioned by a 21 percent increase in international revenue.

The uptick comes as Halliburton increases its presence in overseas markets like China, Australia, Nigeria, and Saudi Arabia. The world’s lead provider of hydraulic-fracturing services has also been heavily active in drilling and pumping projects in the Mediterranean off the coast of Israel, as well as explorations on Alaska’s North Slope, and in the North Sea off the coast of the United Kingdom.

The company’s disclosure of “court facilitated talks” to settle the Gulf of Mexico suits are equally a factor in Monday’s jump in share-price. The company’s willingness to deal with the issue, even though it is not directly a target of any legal action on the part of the federal government, is seen as being particularly favorable for its image, and its share price, as is the fact that Halliburton’s CEO David Lesar expects an increase in prices for international work.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
LGCY Legacy Reserves LP 2.64 0.08 3.24 291,222 Trade
HAL Halliburton Company 47.38 0.22 0.47 3,806,594 Trade


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…